Outcomes of Adults and Children with Primary Mediastinal B-Cell Lymphoma Treated with Dose-Adjusted EPOCH-R

Treatment with dose-adjusted EPOCH (etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone) chemotherapy and rituximab (DA-EPOCH-R) has become the standard of care for primary mediastinal B-cell lymphoma (PMBCL) at many institutions despite limited data in the multi-centre setting. We rep...

詳細記述

保存先:
書誌詳細
出版年:Br J Haematol
主要な著者: Giulino-Roth, Lisa, O’Donohue, Tara, Chen, Zhengming, Bartlett, Nancy L., LaCasce, Ann, Martin-Doyle, William, Barth, Matthew J., Davies, Kimberly, Blum, Kristie A., Christian, Beth, Casulo, Carla, Smith, Sonali M., Godfrey, James, Termuhlen, Amanda, Oberley, Matthew J., Alexander, Sarah, Weitzman, Sheila, Appel, Burton, Mizukawa, Benjamin, Svoboda, Jakub, Afify, Zeinab, Pauly, Melinda, Dave, Hema, Gardner, Rebecca, Stephens, Deborah M., Zeitler, William A., Forlenza, Christopher, Levine, Jennifer, Williams, Michael E., Sima, Jody L., Bollard, Catherine M., Leonard, John P.
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6650639/
https://ncbi.nlm.nih.gov/pubmed/29082519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.14951
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料